,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,21.1,Condition aggravated,6,16103377
1,21.1,Seizure,6,16103377
2,21.1,Neoplasm progression,6,16103377
0,22.0,Gastroenteritis,5,16103400
1,22.0,Product use issue,6,16103400
2,22.0,Incorrect dose administered,6,16103400
0,21.1,Product use in unapproved indication,6,16103401
1,21.1,Adverse event,6,16103401
2,21.1,Packed red blood cell transfusion,6,16103401
0,21.1,Malignant neoplasm progression,6,16103441
1,21.1,Myocarditis,3,16103441
2,21.1,Troponin T increased,3,16103441
0,21.1,Off label use,6,16103455
1,21.1,Drug ineffective,6,16103455
2,21.1,Product use in unapproved indication,6,16103455
0,22.0,Diarrhoea,1,16103468
0,21.1,Vomiting,6,16103470
1,21.1,Nausea,6,16103470
2,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,16103470
3,21.1,Mucosal inflammation,6,16103470
4,21.1,Diarrhoea,6,16103470
5,21.1,Decreased appetite,6,16103470
6,21.1,Pyrexia,6,16103470
0,21.1,Multiple organ dysfunction syndrome,5,16103473
1,21.1,Anaemia,5,16103473
2,21.1,Hypovolaemic shock,5,16103473
3,21.1,Prostate cancer stage IV,5,16103473
4,21.1,Blood creatinine increased,6,16103473
5,21.1,Septic shock,5,16103473
0,21.1,Cholestasis,1,16103475
1,21.1,Diarrhoea,1,16103475
0,22.0,Cystitis haemorrhagic,3,16103487
0,21.1,General physical health deterioration,5,16103489
1,21.1,Genitourinary tract infection,5,16103489
0,21.1,Alopecia,3,16103548
0,22.0,Alopecia,2,16103555
1,22.0,Psychological trauma,6,16103555
0,21.1,Parkinsonism,6,16103573
0,21.1,Laryngeal necrosis,6,16103612
1,21.1,Pharyngeal perforation,6,16103612
0,22.0,Pulmonary thrombosis,6,16103683
0,22.0,Febrile neutropenia,6,16103759
1,22.0,Drug ineffective,6,16103759
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16103759
3,22.0,Diarrhoea,6,16103759
4,22.0,Vomiting,3,16103759
5,22.0,Anaemia,6,16103759
6,22.0,Thrombocytopenia,6,16103759
7,22.0,Drug intolerance,6,16103759
8,22.0,Nausea,3,16103759
9,22.0,Thrombocytopenic purpura,6,16103759
0,22.0,Disease progression,1,16103804
1,22.0,Therapy non-responder,1,16103804
0,22.1,Platelet count decreased,5,16103816
1,22.1,Blood creatinine increased,5,16103816
2,22.1,Haemoglobin decreased,1,16103816
3,22.1,General physical health deterioration,6,16103816
4,22.1,Metastases to meninges,6,16103816
5,22.1,Sepsis,5,16103816
6,22.1,Renal failure,5,16103816
7,22.1,Malignant neoplasm progression,6,16103816
8,22.1,White blood cell count decreased,5,16103816
9,22.1,Breast cancer metastatic,6,16103816
0,21.1,Hyposideraemia,1,16103838
1,21.1,Anaemia,1,16103838
0,22.0,Off label use,6,16104015
1,22.0,Interstitial lung disease,5,16104015
0,21.1,Rash pruritic,2,16104046
1,21.1,Prostatic specific antigen increased,6,16104046
2,21.1,Constipation,6,16104046
3,21.1,Lethargy,2,16104046
4,21.1,Decreased appetite,2,16104046
0,21.1,Ischaemic stroke,1,16104052
0,22.1,Pain,6,16104075
1,22.1,Dysphonia,6,16104075
2,22.1,Paranasal sinus hypersecretion,6,16104075
3,22.1,Dyspnoea exertional,6,16104075
4,22.1,Death,5,16104075
0,21.1,Fatigue,3,16104090
1,21.1,Tremor,6,16104090
2,21.1,Musculoskeletal pain,3,16104090
3,21.1,Hot flush,3,16104090
4,21.1,Arthralgia,3,16104090
5,21.1,Urinary tract infection,1,16104090
6,21.1,Sepsis,1,16104090
0,21.1,Diffuse large B-cell lymphoma,3,16104103
0,21.1,Pyrexia,6,16104121
0,22.1,Injection site ulcer,2,16104153
1,22.1,Adverse event,6,16104153
2,22.1,Induration,2,16104153
3,22.1,Erythema,6,16104153
4,22.1,Induration,6,16104153
0,21.1,Off label use,6,16104311
1,21.1,Acute myeloid leukaemia,6,16104311
2,21.1,Myelodysplastic syndrome,6,16104311
0,21.1,Adverse drug reaction,6,16104356
1,21.1,Urosepsis,6,16104356
2,21.1,Fatigue,6,16104356
0,21.1,Gastrointestinal pain,3,16104402
1,21.1,Abdominal distension,3,16104402
0,22.0,Death,5,16104410
0,21.1,Blood pressure increased,3,16104482
0,21.1,Kidney infection,2,16104525
0,21.1,Injection site haematoma,6,16104602
1,21.1,Product physical consistency issue,6,16104602
2,21.1,Injection site pain,1,16104602
0,21.1,Asthenia,6,16104632
1,21.1,Malaise,6,16104632
2,21.1,Cardiac disorder,6,16104632
3,21.1,Dyspnoea,6,16104632
0,22.0,Hyponatraemia,6,16104698
0,22.0,Syncope,1,16104702
1,22.0,Diverticulitis,1,16104702
0,21.1,Pain,1,16104732
1,21.1,Hypersensitivity,1,16104732
0,22.0,Tremor,2,16104741
1,22.0,Chills,2,16104741
2,22.0,Dizziness,2,16104741
3,22.0,Hot flush,2,16104741
0,22.0,Muscular weakness,1,16104810
1,22.0,Neuralgia,6,16104810
2,22.0,Tinnitus,6,16104810
3,22.0,Burning sensation,6,16104810
4,22.0,Peripheral coldness,1,16104810
5,22.0,Hypoaesthesia,1,16104810
6,22.0,Nausea,1,16104810
7,22.0,Fatigue,1,16104810
8,22.0,Paraesthesia,1,16104810
9,22.0,Myalgia,6,16104810
10,22.0,Neuralgia,3,16104810
0,22.0,Loss of consciousness,6,16104940
1,22.0,Malignant neoplasm progression,3,16104940
2,22.0,Death,5,16104940
0,21.1,Haemoglobin decreased,1,16104942
0,21.1,Pericardial effusion,6,16104981
1,21.1,Axillary pain,6,16104981
0,22.0,Pneumonia,,16105029
0,22.0,Disease progression,,16105039
1,22.0,Toxicity to various agents,,16105039
0,22.0,Urinary tract infection,,16105083
0,22.1,Acute respiratory distress syndrome,5,16105113
0,22.0,Peripheral swelling,,16105153
0,22.0,Pneumonia,6,16105158
1,22.0,Breast cancer recurrent,6,16105158
2,22.0,Asthenia,6,16105158
3,22.0,Nausea,6,16105158
4,22.0,Bronchitis,1,16105158
5,22.0,Interstitial lung disease,6,16105158
6,22.0,Decreased appetite,6,16105158
7,22.0,Pyrexia,6,16105158
8,22.0,Pleural effusion,6,16105158
9,22.0,General physical health deterioration,6,16105158
10,22.0,Candida infection,6,16105158
11,22.0,Influenza,2,16105158
12,22.0,Rhonchi,6,16105158
13,22.0,Pain,6,16105158
14,22.0,Dyspnoea,6,16105158
15,22.0,Cough,6,16105158
16,22.0,Vulvovaginal mycotic infection,6,16105158
17,22.0,Diarrhoea,6,16105158
0,22.0,Oral cavity fistula,1,16105240
1,22.0,Renal impairment,6,16105240
2,22.0,Blood creatinine abnormal,6,16105240
3,22.0,Fistula discharge,1,16105240
4,22.0,Osteonecrosis of jaw,2,16105240
0,21.1,Pneumonia,5,16105242
1,21.1,Neutropenia,5,16105242
0,21.1,Pyrexia,6,16105243
1,21.1,Death,5,16105243
2,21.1,Hypothermia,6,16105243
0,21.1,Death,5,16105257
0,21.1,Malaise,3,16105258
1,21.1,Malignant neoplasm progression,6,16105258
0,21.1,Urinary tract infection,5,16105263
1,21.1,Platelet count decreased,5,16105263
2,21.1,Loss of consciousness,5,16105263
3,21.1,Cerebral haemorrhage,5,16105263
0,22.0,Anaemia,6,16105298
1,22.0,Product use in unapproved indication,6,16105298
2,22.0,Fatigue,6,16105298
3,22.0,Restless legs syndrome,1,16105298
4,22.0,Gastrointestinal toxicity,1,16105298
5,22.0,Sensory disturbance,6,16105298
6,22.0,Cancer pain,1,16105298
7,22.0,Therapeutic product effect incomplete,6,16105298
8,22.0,Drug intolerance,6,16105298
0,21.1,Platelet count decreased,1,16105324
1,21.1,Bone marrow failure,1,16105324
0,21.1,Paraesthesia,6,16105333
1,21.1,Fatigue,6,16105333
2,21.1,Polyneuropathy,6,16105333
3,21.1,Pain in extremity,6,16105333
4,21.1,Arthralgia,6,16105333
5,21.1,Pain,6,16105333
0,21.1,Anaemia,1,16105341
0,21.1,Breast cancer stage II,6,16105389
1,21.1,Malignant neoplasm progression,6,16105389
2,21.1,PIK3CA-activated mutation,6,16105389
0,21.1,Febrile neutropenia,3,16105441
0,22.0,Diarrhoea,6,16105448
1,22.0,Bone marrow failure,3,16105448
2,22.0,Nausea,6,16105448
3,22.0,Fatigue,6,16105448
4,22.0,White blood cell count decreased,3,16105448
5,22.0,Rash pruritic,1,16105448
0,21.1,Death,5,16105457
0,21.1,Off label use,6,16105504
1,21.1,Intentional product use issue,6,16105504
2,21.1,Disease progression,3,16105504
0,21.1,Breast cancer,6,16105542
1,21.1,Malignant neoplasm progression,6,16105542
0,21.1,Ascites,6,16105598
0,22.0,Fatigue,,16105601
1,22.0,Headache,,16105601
0,22.0,Adverse reaction,,16105604
0,21.1,Pancreatitis acute,2,16105625
1,21.1,Abdominal pain,1,16105625
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,16105638
1,21.1,Decreased appetite,6,16105638
2,21.1,Thrombocytopenia,6,16105638
3,21.1,Hypertension,6,16105638
4,21.1,Liver function test abnormal,6,16105638
5,21.1,Gastrointestinal toxicity,6,16105638
6,21.1,Neutropenia,6,16105638
7,21.1,Fatigue,6,16105638
8,21.1,Mucosal inflammation,6,16105638
0,21.1,Neutropenia,3,16105654
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,3,16105654
2,21.1,Thrombocytopenia,3,16105654
3,21.1,Arthralgia,3,16105654
4,21.1,Hypertension,3,16105654
5,21.1,Fatigue,3,16105654
0,21.1,Osteonecrosis of jaw,3,16105655
1,21.1,Drug interaction,3,16105655
0,21.1,Diabetes mellitus,3,16105659
0,21.1,Febrile neutropenia,1,16105750
1,21.1,Neutrophil count decreased,6,16105750
2,21.1,Mouth haemorrhage,6,16105750
3,21.1,Hypertension,6,16105750
4,21.1,Bone marrow failure,6,16105750
5,21.1,Proteinuria,6,16105750
0,21.1,Malignant neoplasm progression,3,16105775
1,21.1,Breast cancer,3,16105775
0,21.1,Death,5,16105788
0,21.1,Polyneuropathy,6,16105800
0,22.0,Eosinophilic pneumonia,2,16105805
0,21.1,Hyposideraemia,1,16105810
1,21.1,Anaemia,1,16105810
0,21.1,Tachycardia,1,16105836
1,21.1,Angioedema,1,16105836
2,21.1,Oxygen saturation decreased,1,16105836
3,21.1,Prolonged expiration,1,16105836
0,21.1,Hepatitis,1,16105854
0,22.0,Nausea,6,16105872
1,22.0,Fatigue,3,16105872
2,22.0,Blood sodium decreased,6,16105872
3,22.0,Muscle spasms,1,16105872
4,22.0,Diarrhoea,1,16105872
5,22.0,Headache,3,16105872
6,22.0,Decreased appetite,2,16105872
7,22.0,Cholelithiasis,6,16105872
8,22.0,Malignant neoplasm progression,6,16105872
9,22.0,Pain,3,16105872
10,22.0,Pancreatitis,6,16105872
11,22.0,Pancreatic cyst,6,16105872
12,22.0,Renal cancer,6,16105872
13,22.0,Hypertension,6,16105872
0,21.1,Metastases to bone,3,16105896
1,21.1,Nausea,2,16105896
2,21.1,Metastases to central nervous system,5,16105896
3,21.1,Decreased appetite,2,16105896
4,21.1,Non-small cell lung cancer stage IV,6,16105896
5,21.1,Diarrhoea,1,16105896
6,21.1,Malignant neoplasm progression,6,16105896
0,21.1,Pain,6,16105946
1,21.1,Alopecia,3,16105946
2,21.1,Anxiety,6,16105946
3,21.1,Emotional distress,6,16105946
4,21.1,Psychological trauma,6,16105946
5,21.1,Impaired quality of life,6,16105946
0,22.0,Psychological trauma,6,16105948
1,22.0,Alopecia,2,16105948
0,22.0,Alopecia,2,16105957
0,22.0,Neoplasm progression,6,16106008
1,22.0,Infection,6,16106008
0,21.1,Toxicity to various agents,1,16106013
1,21.1,General physical health deterioration,1,16106013
0,21.1,Hypertransaminasaemia,1,16106015
0,21.1,Acute myeloid leukaemia,3,16106035
0,21.1,Dizziness,1,16106050
1,21.1,Tachycardia,1,16106050
2,21.1,Hyperhidrosis,1,16106050
3,21.1,Erythema,1,16106050
4,21.1,Cough,1,16106050
0,21.1,Breast cancer metastatic,6,16106068
1,21.1,Malignant neoplasm progression,6,16106068
0,22.1,Angina pectoris,1,16106074
0,21.1,Dry mouth,6,16106130
1,21.1,Fatigue,6,16106130
2,21.1,Hypoacusis,6,16106130
3,21.1,Dyspepsia,6,16106130
4,21.1,Dysgeusia,6,16106130
5,21.1,Insomnia,6,16106130
6,21.1,Tinnitus,6,16106130
0,22.0,Interstitial lung disease,5,16106150
1,22.0,Radiation pneumonitis,6,16106150
2,22.0,Pulmonary embolism,6,16106150
3,22.0,Thrombosis,6,16106150
4,22.0,Respiratory failure,5,16106150
5,22.0,Decreased ventricular afterload,6,16106150
6,22.0,Myocarditis,2,16106150
7,22.0,Venous thrombosis limb,6,16106150
8,22.0,Pneumonia bacterial,6,16106150
9,22.0,Myocardial necrosis marker increased,2,16106150
0,21.1,Death,5,16106194
0,21.1,Gastric cancer,5,16106229
0,21.1,Drug resistance,5,16106236
1,21.1,Malignant neoplasm progression,5,16106236
2,21.1,EGFR gene mutation,5,16106236
0,21.1,Hypotension,1,16106270
1,21.1,Hypothermia,1,16106270
2,21.1,Disturbance in attention,1,16106270
3,21.1,Diarrhoea,1,16106270
0,21.1,Nausea,1,16106298
1,21.1,Presyncope,1,16106298
2,21.1,Ejection fraction decreased,1,16106298
3,21.1,Fatigue,3,16106298
4,21.1,Diarrhoea,1,16106298
5,21.1,Diarrhoea,1,16106298
6,21.1,Alopecia,1,16106298
7,21.1,Pleural effusion,1,16106298
8,21.1,Dizziness,1,16106298
9,21.1,Constipation,1,16106298
10,21.1,Back pain,1,16106298
11,21.1,Retinal detachment,4,16106298
12,21.1,Weight decreased,1,16106298
13,21.1,Dyspnoea,1,16106298
0,21.1,Product use in unapproved indication,3,16106305
1,21.1,Vision blurred,1,16106305
0,21.1,Joint swelling,6,16106306
1,21.1,Increased appetite,6,16106306
2,21.1,Product use in unapproved indication,3,16106306
3,21.1,Influenza,6,16106306
4,21.1,Peripheral swelling,6,16106306
0,21.1,Product use in unapproved indication,3,16106317
1,21.1,Dyspnoea,6,16106317
0,21.1,Product use in unapproved indication,1,16106324
1,21.1,Adverse drug reaction,6,16106324
0,22.0,Hospitalisation,,16106341
0,21.1,Death,5,16106359
0,22.0,Death,,16106383
0,21.1,Product use in unapproved indication,3,16106416
1,21.1,Skin exfoliation,6,16106416
2,21.1,Vision blurred,6,16106416
0,21.1,Product use in unapproved indication,6,16106423
1,21.1,Lung disorder,6,16106423
2,21.1,Temperature intolerance,6,16106423
0,21.1,Intestinal perforation,5,16106433
0,22.0,Incorrect dose administered,6,16106465
1,22.0,Weight decreased,6,16106465
2,22.0,Decreased appetite,6,16106465
0,22.0,Metastasis,6,16106479
1,22.0,Metastases to bone,6,16106479
2,22.0,Metastases to lung,6,16106479
3,22.0,Malignant neoplasm progression,6,16106479
4,22.0,Infection,6,16106479
5,22.0,Drug ineffective,6,16106479
6,22.0,Breast cancer,6,16106479
0,21.1,Urinary tract infection,1,16106491
1,21.1,Hypothyroidism,2,16106491
2,21.1,Anaemia,1,16106491
3,21.1,Neutropenia,6,16106491
4,21.1,Cystitis,1,16106491
5,21.1,Leukopenia,1,16106491
6,21.1,Thrombocytopenia,1,16106491
0,22.0,Neutropenic sepsis,1,16106492
1,22.0,Intestinal perforation,5,16106492
0,21.1,Diarrhoea,5,16106495
1,21.1,Neutrophil count decreased,5,16106495
2,21.1,Pain,5,16106495
3,21.1,Neutrophil count decreased,5,16106495
4,21.1,Diarrhoea,5,16106495
5,21.1,Diarrhoea,5,16106495
6,21.1,Neoplasm progression,5,16106495
7,21.1,Neutrophil count decreased,5,16106495
8,21.1,Stomatitis,5,16106495
9,21.1,Death,5,16106495
10,21.1,Anaemia,5,16106495
11,21.1,Peripheral sensory neuropathy,5,16106495
0,22.0,Disease progression,5,16106499
0,22.0,Pneumonia,6,16106506
1,22.0,Urinary tract infection,6,16106506
2,22.0,Diarrhoea,2,16106506
3,22.0,Decreased appetite,6,16106506
0,21.1,Death,5,16106510
0,21.1,Haematotoxicity,6,16106513
1,21.1,Skin lesion,3,16106513
2,21.1,Death,5,16106513
3,21.1,Disease progression,3,16106513
4,21.1,Infection,6,16106513
5,21.1,General physical health deterioration,6,16106513
6,21.1,Off label use,6,16106513
0,21.1,Death,5,16106549
0,21.1,Cerebrovascular accident,,16106576
1,21.1,Hypertensive emergency,1,16106576
2,21.1,Off label use,,16106576
0,21.1,Pulmonary congestion,6,16106591
1,21.1,Streptococcus test positive,6,16106591
2,21.1,Pyrexia,3,16106591
3,21.1,Lung consolidation,6,16106591
4,21.1,Pleural effusion,6,16106591
5,21.1,Dyspnoea,6,16106591
6,21.1,Respiratory failure,5,16106591
7,21.1,Influenza B virus test positive,6,16106591
8,21.1,Atrial fibrillation,3,16106591
9,21.1,Upper respiratory tract infection,6,16106591
10,21.1,Atelectasis,6,16106591
0,22.0,Ventricular fibrillation,5,16106594
1,22.0,Malignant neoplasm progression,5,16106594
0,21.1,Death,5,16106597
0,21.1,Death,5,16106633
1,21.1,Product use in unapproved indication,6,16106633
0,22.0,Death,5,16106646
0,21.1,Lower limb fracture,3,16106698
1,21.1,Product dose omission,3,16106698
0,22.0,Diarrhoea,1,16106728
1,22.0,Sepsis,,16106728
2,22.0,Pain in extremity,1,16106728
3,22.0,Off label use,,16106728
0,22.0,Nephropathy toxic,6,16106757
1,22.0,Systemic lupus erythematosus,4,16106757
2,22.0,Skin hypopigmentation,6,16106757
0,21.1,Off label use,6,16106760
1,21.1,Recurrent cancer,6,16106760
0,22.0,Diarrhoea,1,16106784
1,22.0,Decreased appetite,1,16106784
2,22.0,Nausea,1,16106784
0,22.0,Malignant neoplasm progression,1,16106833
1,22.0,Inflammation,6,16106833
2,22.0,Platelet count decreased,6,16106833
3,22.0,Off label use,3,16106833
4,22.0,Product use issue,3,16106833
5,22.0,Pruritus,6,16106833
6,22.0,Asthenia,6,16106833
7,22.0,Dry skin,6,16106833
8,22.0,Fatigue,6,16106833
0,22.0,Febrile neutropenia,1,16106916
1,22.0,Anaemia,2,16106916
2,22.0,Frequent bowel movements,6,16106916
3,22.0,White blood cell count decreased,1,16106916
4,22.0,Thrombocytopenia,2,16106916
5,22.0,Anal incontinence,6,16106916
6,22.0,Anal haemorrhage,6,16106916
0,22.1,Malignant neoplasm progression,6,16106925
0,21.1,Disease progression,3,16106989
1,21.1,Internal haemorrhage,3,16106989
0,22.0,Bipolar disorder,1,16107048
0,22.0,Malignant neoplasm progression,6,16107074
0,22.0,Liver disorder,6,16107079
1,22.0,Pneumonitis,1,16107079
2,22.0,Rash generalised,6,16107079
0,22.0,Cough,5,16107081
1,22.0,Dyspnoea,3,16107081
2,22.0,Pain,5,16107081
3,22.0,Weight decreased,5,16107081
4,22.0,Pneumonitis,5,16107081
0,22.0,Decreased appetite,1,16107172
1,22.0,Atrial fibrillation,1,16107172
2,22.0,Stomatitis,1,16107172
3,22.0,Drug ineffective,6,16107172
4,22.0,Drug eruption,1,16107172
5,22.0,Dizziness,6,16107172
6,22.0,Feeding disorder,1,16107172
7,22.0,Electrocardiogram QT prolonged,1,16107172
8,22.0,Altered state of consciousness,1,16107172
9,22.0,Liver disorder,1,16107172
10,22.0,Pyrexia,1,16107172
11,22.0,Dehydration,1,16107172
0,22.0,Malignant neoplasm progression,6,16107173
1,22.0,Metastasis,6,16107173
2,22.0,Dermatitis acneiform,2,16107173
3,22.0,Metastases to lung,2,16107173
4,22.0,Off label use,6,16107173
0,22.0,Cystitis,1,16107281
0,21.1,Death,5,16107284
0,21.1,Blood urine present,3,16107357
1,21.1,Pulmonary embolism,5,16107357
2,21.1,Pyrexia,1,16107357
3,21.1,Nausea,3,16107357
4,21.1,Eating disorder,3,16107357
5,21.1,Dysuria,3,16107357
6,21.1,Vomiting,3,16107357
0,22.0,Colitis,2,16107361
1,22.0,Febrile neutropenia,2,16107361
2,22.0,Decreased activity,6,16107361
3,22.0,Hypotension,6,16107361
0,22.0,Bone marrow failure,6,16107370
1,22.0,Leukopenia,6,16107370
2,22.0,Asthenia,6,16107370
3,22.0,Headache,6,16107370
4,22.0,Influenza,6,16107370
5,22.0,Escherichia urinary tract infection,6,16107370
6,22.0,Oropharyngeal pain,6,16107370
7,22.0,Blood thyroid stimulating hormone decreased,6,16107370
8,22.0,Immune-mediated hepatitis,3,16107370
9,22.0,Pathogen resistance,6,16107370
10,22.0,Neutropenia,1,16107370
11,22.0,Trigeminal neuralgia,6,16107370
12,22.0,Chronic obstructive pulmonary disease,6,16107370
13,22.0,Myalgia,6,16107370
0,21.1,Product use in unapproved indication,6,16107460
1,21.1,Disease progression,6,16107460
0,22.1,Product use in unapproved indication,6,16107474
1,22.1,Dizziness,6,16107474
2,22.1,Nausea,6,16107474
3,22.1,Diarrhoea,6,16107474
4,22.1,Vomiting,6,16107474
0,21.1,Vision blurred,6,16107483
1,21.1,Product use in unapproved indication,6,16107483
0,21.1,Anaemia,6,16107549
1,21.1,Product use issue,6,16107549
2,21.1,Spinal osteoarthritis,6,16107549
3,21.1,Hypertension,6,16107549
4,21.1,Off label use,6,16107549
5,21.1,Malignant neoplasm of uterine adnexa,6,16107549
6,21.1,Lymphocele,6,16107549
0,21.1,Rash,1,16107616
1,21.1,Carcinoembryonic antigen increased,2,16107616
2,21.1,Malignant neoplasm progression,2,16107616
0,22.0,Internal haemorrhage,3,16107627
1,22.0,Adverse drug reaction,3,16107627
2,22.0,Death,5,16107627
3,22.0,Blood disorder,3,16107627
0,21.1,Product use in unapproved indication,6,16107664
1,21.1,Obstruction,6,16107664
0,22.0,Body height decreased,6,16107670
1,22.0,Nausea,3,16107670
2,22.0,Full blood count decreased,6,16107670
3,22.0,Blood pressure increased,1,16107670
4,22.0,Vomiting,6,16107670
5,22.0,Carbohydrate antigen 125 increased,3,16107670
6,22.0,Product dose omission,6,16107670
7,22.0,Ovarian cancer recurrent,6,16107670
8,22.0,Neutrophil count decreased,6,16107670
9,22.0,Off label use,6,16107670
10,22.0,Anaemia,1,16107670
11,22.0,Fatigue,3,16107670
12,22.0,White blood cell count decreased,3,16107670
13,22.0,Headache,6,16107670
0,21.1,Diarrhoea,1,16107714
1,21.1,Neutrophil count decreased,1,16107714
2,21.1,Decreased appetite,1,16107714
3,21.1,White blood cell count decreased,1,16107714
4,21.1,Neutrophil count decreased,1,16107714
5,21.1,Fatigue,6,16107714
6,21.1,Dehydration,1,16107714
7,21.1,Leukopenia,1,16107714
8,21.1,General physical health deterioration,1,16107714
0,21.1,Cognitive disorder,6,16107743
1,21.1,Performance status decreased,6,16107743
2,21.1,Encephalitis,6,16107743
3,21.1,Confusional state,3,16107743
0,22.0,Ovarian cancer recurrent,6,16107747
1,22.0,Malignant neoplasm progression,6,16107747
0,22.0,Pancreatitis acute,1,16107780
0,21.1,Pulmonary embolism,5,16107786
1,21.1,Haemoptysis,6,16107786
2,21.1,Dyspnoea,6,16107786
3,21.1,Pleurodesis,6,16107786
0,21.1,Dysuria,2,16107797
1,21.1,Urinary incontinence,2,16107797
2,21.1,Microcytic anaemia,6,16107797
3,21.1,Micturition urgency,2,16107797
4,21.1,Product use in unapproved indication,6,16107797
5,21.1,Nocturia,2,16107797
6,21.1,Perineal pain,1,16107797
7,21.1,Urinary tract pain,1,16107797
0,22.0,Interstitial lung disease,2,16107800
1,22.0,Pancytopenia,1,16107800
2,22.0,Anaemia,1,16107800
3,22.0,Decreased appetite,6,16107800
0,22.0,Faeces discoloured,3,16107801
1,22.0,Epistaxis,3,16107801
2,22.0,Rhinorrhoea,3,16107801
3,22.0,Constipation,3,16107801
4,22.0,Cough,6,16107801
5,22.0,Dizziness,3,16107801
6,22.0,Dyspnoea,3,16107801
0,21.1,Respiratory failure,5,16107852
1,21.1,Pulmonary embolism,5,16107852
2,21.1,Pneumonitis,6,16107852
3,21.1,Neoplasm progression,6,16107852
4,21.1,Cardiac failure,5,16107852
0,21.1,Pharyngeal paraesthesia,1,16107854
1,21.1,Hot flush,1,16107854
2,21.1,Paraesthesia,1,16107854
3,21.1,Dyspnoea,1,16107854
0,22.0,Hypoacusis,3,16107898
1,22.0,Transient ischaemic attack,6,16107898
2,22.0,Cataract,3,16107898
0,21.1,Oesophagitis,6,16107950
1,21.1,Gastritis,1,16107950
0,21.1,Metastases to lung,6,16107953
1,21.1,Metastases to bone,6,16107953
0,21.1,Transaminases increased,1,16107980
0,21.1,Product use in unapproved indication,6,16108064
1,21.1,Liver function test abnormal,6,16108064
0,21.1,Infusion related reaction,1,16108162
0,21.1,Rectal cancer,3,16108170
1,21.1,Weight decreased,3,16108170
0,22.0,Colitis,6,16108179
0,21.1,Anaemia,1,16108180
0,22.0,Uterine cancer,6,16108183
0,21.1,Nausea,2,16108189
1,21.1,Vomiting,2,16108189
0,22.0,Pneumonitis,6,16108192
1,22.0,Pulmonary embolism,6,16108192
2,22.0,Syncope,3,16108192
3,22.0,Acute kidney injury,6,16108192
4,22.0,Hypotension,6,16108192
5,22.0,Pneumocystis jirovecii pneumonia,6,16108192
0,22.0,Pancreatitis,5,16108200
1,22.0,Ischaemic stroke,6,16108200
2,22.0,Malignant neoplasm progression,5,16108200
3,22.0,Hepatitis,5,16108200
4,22.0,Cholestasis,6,16108200
5,22.0,Multiple organ dysfunction syndrome,5,16108200
0,22.0,Tumour pseudoprogression,6,16108213
0,22.0,Pneumonitis,2,16108238
0,22.0,Anxiety,1,16108247
0,22.0,Appendicitis perforated,2,16108252
0,22.0,Hydrothorax,6,16108276
0,22.0,Weight decreased,6,16108283
1,22.0,Syncope,6,16108283
2,22.0,Ascites,6,16108283
3,22.0,Ventricular tachycardia,6,16108283
4,22.0,Muscular weakness,6,16108283
5,22.0,Hypercalcaemia,6,16108283
6,22.0,Lumbar vertebral fracture,6,16108283
7,22.0,Lymphadenopathy mediastinal,6,16108283
8,22.0,Pleural effusion,6,16108283
9,22.0,Autoimmune thyroiditis,6,16108283
10,22.0,Autoimmune hypothyroidism,6,16108283
11,22.0,Anaemia of malignant disease,6,16108283
12,22.0,General physical health deterioration,6,16108283
0,22.0,Abdominal discomfort,3,16108320
1,22.0,Blood pressure decreased,3,16108320
2,22.0,Mean cell haemoglobin decreased,3,16108320
3,22.0,Spinal pain,3,16108320
4,22.0,Drug hypersensitivity,3,16108320
5,22.0,Infusion site haemorrhage,3,16108320
6,22.0,Incontinence,3,16108320
7,22.0,Abdominal distension,3,16108320
8,22.0,Blood cholesterol increased,3,16108320
9,22.0,Metastases to bone,3,16108320
10,22.0,Back pain,3,16108320
11,22.0,Fatigue,3,16108320
12,22.0,Gamma-glutamyltransferase decreased,3,16108320
13,22.0,Neutrophil count decreased,3,16108320
14,22.0,Infusion site coldness,3,16108320
15,22.0,Gastritis,3,16108320
16,22.0,Hypoaesthesia,3,16108320
17,22.0,Dehydration,3,16108320
18,22.0,Injection site bruising,3,16108320
19,22.0,Injection site erythema,3,16108320
20,22.0,Post-traumatic neck syndrome,3,16108320
21,22.0,Toothache,3,16108320
22,22.0,Flushing,3,16108320
23,22.0,Pain in extremity,3,16108320
24,22.0,Oedema peripheral,3,16108320
25,22.0,Headache,3,16108320
26,22.0,Chest pain,3,16108320
27,22.0,Peripheral swelling,3,16108320
28,22.0,Road traffic accident,3,16108320
29,22.0,Impaired healing,3,16108320
30,22.0,Blood potassium increased,3,16108320
31,22.0,Muscle spasms,3,16108320
32,22.0,Dizziness,3,16108320
33,22.0,Chills,3,16108320
34,22.0,Injection site swelling,3,16108320
35,22.0,Hepatic function abnormal,3,16108320
36,22.0,Pain in jaw,3,16108320
37,22.0,Blood creatinine decreased,3,16108320
38,22.0,Feeling hot,3,16108320
39,22.0,Asthenia,3,16108320
40,22.0,Decreased appetite,3,16108320
41,22.0,Injection site mass,3,16108320
42,22.0,Paraesthesia,3,16108320
43,22.0,Anxiety,3,16108320
44,22.0,Infusion site induration,3,16108320
45,22.0,Peripheral coldness,3,16108320
46,22.0,Migraine,3,16108320
47,22.0,Poor venous access,3,16108320
48,22.0,Vein disorder,3,16108320
49,22.0,Platelet count decreased,3,16108320
50,22.0,Pyrexia,3,16108320
51,22.0,Influenza like illness,3,16108320
52,22.0,Bone pain,3,16108320
53,22.0,Rash,3,16108320
54,22.0,Retinal detachment,3,16108320
55,22.0,Abdominal pain upper,3,16108320
56,22.0,Body temperature decreased,3,16108320
57,22.0,Contusion,3,16108320
58,22.0,White blood cell count decreased,3,16108320
59,22.0,Urticaria,3,16108320
60,22.0,Malaise,3,16108320
61,22.0,Drug ineffective,3,16108320
62,22.0,Feeling cold,3,16108320
63,22.0,Vasodilatation,3,16108320
64,22.0,Immunodeficiency,3,16108320
65,22.0,Arthralgia,3,16108320
66,22.0,Pain,3,16108320
67,22.0,Nausea,3,16108320
0,21.1,Malignant neoplasm progression,6,16108323
1,21.1,Cardiac dysfunction,6,16108323
0,21.1,Death,5,16108496
0,22.0,Pancytopenia,1,16108501
0,22.0,Mouth ulceration,6,16108567
1,22.0,Stomatitis,6,16108567
2,22.0,Epistaxis,6,16108567
3,22.0,Bronchitis,2,16108567
4,22.0,Constipation,6,16108567
5,22.0,Musculoskeletal pain,6,16108567
6,22.0,Insomnia,6,16108567
7,22.0,Depression,6,16108567
8,22.0,Diarrhoea,3,16108567
9,22.0,Blood pressure increased,6,16108567
10,22.0,Oedema peripheral,6,16108567
11,22.0,Weight decreased,6,16108567
12,22.0,Heart rate decreased,6,16108567
13,22.0,Pain in extremity,6,16108567
14,22.0,Blood calcium decreased,1,16108567
15,22.0,Fatigue,6,16108567
16,22.0,Urinary tract infection,6,16108567
17,22.0,Pneumonia,3,16108567
18,22.0,Rash,6,16108567
19,22.0,Nasal congestion,6,16108567
0,22.0,Pallor,1,16108589
1,22.0,Wheezing,1,16108589
2,22.0,Cardiac failure acute,1,16108589
3,22.0,Diabetes mellitus inadequate control,,16108589
4,22.0,Contusion,,16108589
5,22.0,Chest pain,1,16108589
6,22.0,Traumatic fracture,,16108589
7,22.0,Oedema peripheral,1,16108589
8,22.0,Renal impairment,,16108589
9,22.0,Hyperuricaemia,3,16108589
10,22.0,Dyspnoea,1,16108589
11,22.0,Chest discomfort,1,16108589
12,22.0,Cardiac failure acute,1,16108589
13,22.0,Blood glucose decreased,,16108589
14,22.0,Malaise,1,16108589
15,22.0,Cold sweat,1,16108589
16,22.0,Metastases to lung,,16108589
17,22.0,Osteonecrosis of jaw,,16108589
18,22.0,Osteonecrosis of jaw,,16108589
19,22.0,Fall,,16108589
20,22.0,Anaemia,,16108589
21,22.0,Pyrexia,,16108589
22,22.0,Hyperhidrosis,1,16108589
0,21.1,Acute leukaemia,3,16108654
0,21.1,Pyrexia,1,16108655
1,21.1,Chills,1,16108655
0,21.1,Adrenal haemorrhage,6,16108668
0,21.1,Off label use,6,16108732
1,21.1,Breast cancer metastatic,6,16108732
2,21.1,Osteopenia,6,16108732
3,21.1,Haemarthrosis,6,16108732
4,21.1,Atypical femur fracture,6,16108732
0,22.0,Lymphadenopathy,1,16108780
0,22.0,Abdominal pain upper,6,16108801
1,22.0,Abdominal pain,6,16108801
2,22.0,Diarrhoea,1,16108801
3,22.0,Blood creatinine increased,1,16108801
4,22.0,Pancreatitis acute,2,16108801
5,22.0,Atypical mycobacterial infection,3,16108801
6,22.0,Epistaxis,1,16108801
7,22.0,Non-small cell lung cancer stage IV,5,16108801
8,22.0,Malignant neoplasm progression,5,16108801
9,22.0,Peritoneal abscess,3,16108801
10,22.0,Abdominal pain upper,6,16108801
11,22.0,Malaise,3,16108801
0,21.1,Death,5,16108811
1,21.1,Malaise,3,16108811
0,22.0,Diarrhoea,1,16108872
1,22.0,Nausea,1,16108872
2,22.0,Fatigue,3,16108872
3,22.0,Abdominal pain,1,16108872
4,22.0,Diarrhoea,3,16108872
5,22.0,Hypokalaemia,1,16108872
6,22.0,Decreased appetite,6,16108872
0,22.1,Rash,1,16109303
1,22.1,Hypersensitivity,3,16109303
0,21.1,Respiratory disorder,1,16109310
1,21.1,Diabetes mellitus inadequate control,1,16109310
2,21.1,Injection site pain,1,16109310
3,21.1,Intentional overdose,1,16109310
0,22.0,Energy increased,6,16109314
1,22.0,Insomnia,6,16109314
0,22.0,Mean platelet volume decreased,3,16109321
1,22.0,Malaise,3,16109321
2,22.0,Dyspnoea exertional,3,16109321
3,22.0,Speech disorder,3,16109321
4,22.0,Urogenital prolapse,3,16109321
5,22.0,Influenza,3,16109321
6,22.0,Palpitations,3,16109321
7,22.0,Abdominal discomfort,3,16109321
8,22.0,Muscular weakness,3,16109321
9,22.0,Thinking abnormal,3,16109321
10,22.0,Lacrimation increased,3,16109321
11,22.0,Pruritus,3,16109321
12,22.0,Depression,3,16109321
13,22.0,Diarrhoea,3,16109321
14,22.0,Stomatitis,3,16109321
15,22.0,Blood pressure increased,3,16109321
16,22.0,Aura,3,16109321
17,22.0,Toothache,3,16109321
18,22.0,Oxygen saturation decreased,3,16109321
19,22.0,Uterine prolapse,3,16109321
20,22.0,Memory impairment,3,16109321
21,22.0,Vomiting,3,16109321
22,22.0,Laryngitis,3,16109321
23,22.0,Tooth infection,3,16109321
24,22.0,Hypotension,3,16109321
25,22.0,Dysgeusia,3,16109321
0,21.1,Oxygen saturation decreased,1,16109358
1,21.1,Pyrexia,1,16109358
0,21.1,Flushing,3,16109411
1,21.1,Renal disorder,1,16109411
2,21.1,Bone pain,3,16109411
3,21.1,Constipation,2,16109411
0,22.0,Pulmonary embolism,2,16109416
0,21.1,Infection,6,16109427
0,21.1,Musculoskeletal discomfort,1,16109433
1,21.1,Feeling hot,1,16109433
2,21.1,Infusion related reaction,1,16109433
0,21.1,Metastases to liver,6,16109492
1,21.1,Colorectal cancer stage IV,6,16109492
2,21.1,Malignant neoplasm progression,6,16109492
3,21.1,Neuropathy peripheral,6,16109492
0,21.1,Impaired healing,1,16109493
1,21.1,Diarrhoea,6,16109493
2,21.1,Metastases to skin,1,16109493
0,21.1,Product supply issue,6,16109545
1,21.1,No adverse event,6,16109545
2,21.1,Product dose omission,6,16109545
0,21.1,Abdominal pain upper,1,16109593
1,21.1,Pruritus,1,16109593
2,21.1,Erythema,1,16109593
0,21.1,Pain in jaw,6,16109635
1,21.1,Fatigue,6,16109635
0,22.0,Prostate cancer,6,16109798
1,22.0,Feeling abnormal,3,16109798
2,22.0,Fatigue,3,16109798
0,22.0,Cardiac failure,3,16109800
1,22.0,Cough,6,16109800
2,22.0,Pleural effusion,6,16109800
3,22.0,Dyspnoea,1,16109800
4,22.0,Hypokalaemia,6,16109800
5,22.0,Pericardial effusion,6,16109800
6,22.0,Hyperuricaemia,6,16109800
7,22.0,Atrial fibrillation,3,16109800
8,22.0,Peripheral swelling,1,16109800
0,22.0,Therapeutic response decreased,6,16109802
1,22.0,Neuropathy peripheral,6,16109802
2,22.0,Platelet count decreased,1,16109802
3,22.0,White blood cell count decreased,1,16109802
4,22.0,Neutrophil count decreased,1,16109802
0,21.1,Anaphylactic shock,1,16109811
0,21.1,Cardiac disorder,6,16109815
1,21.1,Haemorrhage urinary tract,6,16109815
2,21.1,Chest pain,6,16109815
3,21.1,Drug ineffective,6,16109815
0,21.1,Abdominal pain upper,2,16109819
1,21.1,Asthenia,2,16109819
0,21.1,Terminal state,6,16109889
0,21.1,Treatment failure,6,16109897
1,21.1,Incorrect dose administered,6,16109897
2,21.1,Off label use,6,16109897
0,21.1,Transplant rejection,5,16109902
1,21.1,Hepatic failure,5,16109902
0,22.0,Sepsis,5,16109906
0,21.1,Osteonecrosis of jaw,2,16109909
1,21.1,Jugular vein thrombosis,6,16109909
2,21.1,Lemierre syndrome,2,16109909
3,21.1,Necrotising fasciitis,2,16109909
0,21.1,Asthenia,2,16109937
1,21.1,Abdominal pain upper,2,16109937
0,21.1,Prescribed underdose,6,16109954
1,21.1,Bladder cancer,5,16109954
0,21.1,Metastatic malignant melanoma,5,16109999
0,22.0,Disease progression,6,16110035
0,21.1,Hepatocellular injury,1,16110083
1,21.1,Hepatitis cholestatic,1,16110083
0,22.0,Ankylosing spondylitis,3,16110085
0,21.1,Hyperbilirubinaemia,3,16110086
1,21.1,Hepatitis,3,16110086
0,21.1,Platelet count decreased,1,16110094
1,21.1,Immune thrombocytopenic purpura,1,16110094
0,21.1,Asthenia,3,16110102
1,21.1,Dysaesthesia,3,16110102
2,21.1,Foot deformity,3,16110102
3,21.1,Paraesthesia,3,16110102
4,21.1,Neurotoxicity,3,16110102
0,21.1,Hypokalaemia,3,16110106
1,21.1,Diarrhoea,3,16110106
2,21.1,Streptococcal sepsis,5,16110106
3,21.1,Neutropenia,5,16110106
0,21.1,Haemorrhagic transformation stroke,2,16110150
1,21.1,Drug interaction,2,16110150
0,21.1,Dyspnoea at rest,2,16110195
0,22.0,Pruritus,6,16110266
1,22.0,Bronchiolitis,6,16110266
2,22.0,Actinic keratosis,6,16110266
3,22.0,Rash,6,16110266
0,21.1,Malignant neoplasm progression,5,16110283
0,21.1,Dyspnoea,1,16110303
1,21.1,Tachycardia,1,16110303
2,21.1,Oedema,1,16110303
3,21.1,Hypersensitivity,1,16110303
4,21.1,Headache,1,16110303
5,21.1,Bronchospasm,1,16110303
6,21.1,Chest discomfort,1,16110303
7,21.1,Dyspepsia,1,16110303
0,21.1,Haemorrhage,6,16110333
0,21.1,Malaise,6,16110337
0,21.1,Hypertension,6,16110369
1,21.1,Proteinuria,6,16110369
2,21.1,Bone marrow failure,1,16110369
3,21.1,Neurotoxicity,1,16110369
0,21.1,Pancreatitis acute,1,16110420
0,21.1,Pneumonia,6,16110424
0,21.1,Death,5,16110573
0,21.1,Death,5,16110585
0,21.1,Neutrophil count decreased,1,16110589
0,22.1,Vomiting,1,16110611
1,22.1,Pain,1,16110611
2,22.1,Dyspnoea,3,16110611
3,22.1,Haemoptysis,3,16110611
4,22.1,Vertigo,1,16110611
5,22.1,Fatigue,1,16110611
6,22.1,Pruritus,1,16110611
7,22.1,Skin disorder,1,16110611
8,22.1,Oedema,3,16110611
9,22.1,Pneumonitis,1,16110611
10,22.1,Nausea,1,16110611
11,22.1,Diarrhoea,1,16110611
12,22.1,Decreased appetite,1,16110611
13,22.1,Anaemia,1,16110611
14,22.1,Cough,1,16110611
0,21.1,Death,5,16110612
0,21.1,Metastases to lung,6,16110654
1,21.1,Renal failure,6,16110654
2,21.1,Anxiety,6,16110654
0,22.0,Acute coronary syndrome,5,16110660
0,21.1,Death,5,16110661
0,22.0,Chronic obstructive pulmonary disease,5,16110662
1,22.0,Disease progression,6,16110662
0,21.1,Death,5,16110681
0,22.0,Ejection fraction decreased,1,16110779
1,22.0,Cardiotoxicity,6,16110779
0,21.1,Tracheal disorder,6,16110780
1,21.1,Breast cancer,3,16110780
2,21.1,Metastases to lung,6,16110780
3,21.1,Metastases to pleura,6,16110780
4,21.1,Pulmonary tuberculosis,1,16110780
5,21.1,Metastases to lymph nodes,6,16110780
6,21.1,Malignant neoplasm progression,3,16110780
0,22.0,Hospice care,6,16110795
1,22.0,Respiratory failure,5,16110795
0,22.0,Diarrhoea,6,16110814
1,22.0,Pyrexia,6,16110814
2,22.0,Headache,6,16110814
3,22.0,Neck pain,6,16110814
4,22.0,Asthenia,2,16110814
5,22.0,Oropharyngeal pain,6,16110814
6,22.0,Vomiting,6,16110814
0,21.1,Swelling,1,16110817
1,21.1,Abscess,1,16110817
2,21.1,Erythema,1,16110817
0,21.1,Disease progression,6,16110845
1,21.1,Drug intolerance,6,16110845
0,21.1,Immunosuppression,5,16110847
1,21.1,Off label use,6,16110847
2,21.1,Pneumonia,5,16110847
3,21.1,Febrile neutropenia,5,16110847
0,21.1,Metastases to liver,2,16110875
1,21.1,Dyspepsia,2,16110875
2,21.1,Vomiting,2,16110875
3,21.1,Intestinal metastasis,2,16110875
4,21.1,Malignant neoplasm progression,2,16110875
5,21.1,Abdominal pain,2,16110875
6,21.1,Metastases to bladder,2,16110875
7,21.1,Neutropenia,1,16110875
8,21.1,Metastases to stomach,2,16110875
9,21.1,Intestinal stenosis,2,16110875
10,21.1,Metastases to lymph nodes,2,16110875
11,21.1,Haematotoxicity,6,16110875
0,22.0,Gastric cancer,5,16110899
1,22.0,Hypoaesthesia,6,16110899
0,22.1,Decreased appetite,3,16110957
1,22.1,Fall,6,16110957
2,22.1,Fatigue,3,16110957
3,22.1,Aspartate aminotransferase increased,1,16110957
4,22.1,Asthenia,3,16110957
5,22.1,Urinary tract infection,1,16110957
6,22.1,Memory impairment,3,16110957
7,22.1,Hypokalaemia,1,16110957
0,22.0,Injection site pruritus,3,16111014
1,22.0,Hot flush,3,16111014
2,22.0,Injection site swelling,6,16111014
3,22.0,Oedema peripheral,3,16111014
4,22.0,Localised oedema,3,16111014
5,22.0,Eyelid oedema,3,16111014
6,22.0,Injection site erythema,3,16111014
0,22.0,Raynaud^s phenomenon,3,16111028
1,22.0,Interstitial lung disease,3,16111028
2,22.0,Product use in unapproved indication,6,16111028
0,22.1,Haematuria,1,16111057
1,22.1,Hepatic failure,5,16111057
2,22.1,Hypertension,3,16111057
0,22.0,Myalgia,,16111081
1,22.0,Acute kidney injury,,16111081
2,22.0,Thrombocytopenia,,16111081
3,22.0,Pyrexia,,16111081
4,22.0,Muscular weakness,,16111081
5,22.0,Dehydration,,16111081
6,22.0,Arthralgia,,16111081
7,22.0,Headache,,16111081
8,22.0,Non-small cell lung cancer,,16111081
9,22.0,Rhabdomyolysis,,16111081
0,22.0,Death,,16111164
0,21.1,Surgery,6,16111167
0,21.1,Dizziness,6,16111219
0,21.1,Muscular weakness,5,16111259
1,21.1,Neurological decompensation,5,16111259
2,21.1,Cerebrovascular accident,5,16111259
3,21.1,Myocarditis,5,16111259
0,22.0,Death,,16111278
0,22.0,Death,,16111335
0,22.0,Disease progression,,16111344
0,22.0,Cerebrovascular accident,,16111361
0,22.0,Hypertension,1,16111405
1,22.0,Glomerular filtration rate abnormal,3,16111405
2,22.0,Platelet count decreased,3,16111405
3,22.0,Renal impairment,1,16111405
4,22.0,Hypertension,3,16111405
5,22.0,International normalised ratio increased,6,16111405
6,22.0,Renal impairment,3,16111405
0,21.1,Neuropathy peripheral,2,16111414
1,21.1,Dysaesthesia,2,16111414
2,21.1,Paraesthesia,2,16111414
3,21.1,Hypoaesthesia,2,16111414
0,21.1,Breast cancer recurrent,3,16111447
0,22.1,Drug hypersensitivity,6,16111451
0,21.1,Leukopenia,6,16111461
1,21.1,Pneumonia,6,16111461
2,21.1,Decreased appetite,6,16111461
3,21.1,Drug ineffective,6,16111461
4,21.1,Weight decreased,6,16111461
0,21.1,Death,5,16111505
0,21.1,Ovarian disorder,6,16111577
0,22.0,Pneumonia,,16111581
1,22.0,Renal failure,,16111581
0,22.0,Diarrhoea,,16111584
1,22.0,Nausea,,16111584
2,22.0,Abdominal pain,,16111584
3,22.0,Vomiting,,16111584
0,22.0,Dental care,,16111586
0,21.1,Choking,,16111670
1,21.1,Foreign body in respiratory tract,,16111670
0,22.0,Back pain,,16111678
1,22.0,Prostate cancer,,16111678
2,22.0,Cancer pain,,16111678
0,21.1,Off label use,,16111680
1,21.1,Hyperglycaemia,,16111680
2,21.1,Hypertension,,16111680
3,21.1,Product use in unapproved indication,,16111680
0,22.0,Asthenia,3,16111681
1,22.0,Blood pressure increased,3,16111681
2,22.0,Transfusion-associated dyspnoea,6,16111681
3,22.0,Full blood count decreased,3,16111681
4,22.0,Haemoglobin decreased,6,16111681
5,22.0,Platelet count decreased,3,16111681
6,22.0,Diarrhoea,3,16111681
7,22.0,Fatigue,3,16111681
8,22.0,Diarrhoea,3,16111681
9,22.0,White blood cell count decreased,3,16111681
10,22.0,Skin exfoliation,3,16111681
11,22.0,Sleep disorder,3,16111681
12,22.0,Off label use,,16111681
0,21.1,Neurotoxicity,1,16111708
0,22.0,Disease progression,,16111719
0,21.1,Pancytopenia,3,16111747
1,21.1,White blood cell count decreased,2,16111747
2,21.1,Malaise,3,16111747
3,21.1,Hormone-refractory prostate cancer,5,16111747
4,21.1,Bone marrow failure,,16111747
5,21.1,Bone pain,2,16111747
0,21.1,Lymphopenia,2,16111751
1,21.1,Rash maculo-papular,2,16111751
2,21.1,Thrombocytopenia,1,16111751
0,21.1,Impaired quality of life,6,16111780
1,21.1,Anxiety,6,16111780
2,21.1,Alopecia,3,16111780
3,21.1,Emotional distress,6,16111780
4,21.1,Pain,6,16111780
0,21.1,Alopecia,3,16111785
1,21.1,Anxiety,6,16111785
2,21.1,Impaired quality of life,6,16111785
3,21.1,Pain,6,16111785
4,21.1,Emotional distress,6,16111785
0,21.1,Impaired quality of life,6,16111791
1,21.1,Anxiety,6,16111791
2,21.1,Pain,6,16111791
3,21.1,Emotional distress,6,16111791
4,21.1,Alopecia,3,16111791
0,22.0,Malignant neoplasm progression,6,16111851
1,22.0,Osteonecrosis of jaw,6,16111851
2,22.0,Bladder outlet obstruction,6,16111851
3,22.0,Prostatic specific antigen increased,6,16111851
0,21.1,Pseudocirrhosis,2,16111852
0,21.1,Diarrhoea,2,16111870
1,21.1,Hyponatraemia,2,16111870
2,21.1,Dehydration,2,16111870
3,21.1,Insomnia,2,16111870
0,22.0,Anaemia,2,16111939
0,22.0,Rash maculo-papular,1,16111943
1,22.0,Sinus bradycardia,1,16111943
0,21.1,Pulmonary arterial hypertension,3,16111965
0,21.1,Ophthalmic vein thrombosis,6,16111981
0,22.0,Pruritus,6,16111991
1,22.0,Platelet count decreased,2,16111991
2,22.0,Gingival bleeding,6,16111991
3,22.0,Myelodysplastic syndrome,6,16111991
4,22.0,Immune thrombocytopenic purpura,6,16111991
0,21.1,Pancytopenia,2,16112029
0,22.0,Clostridium difficile infection,2,16112042
1,22.0,Tooth extraction,6,16112042
2,22.0,Anaemia,3,16112042
3,22.0,Diarrhoea,3,16112042
4,22.0,Dehydration,1,16112042
5,22.0,Tooth injury,6,16112042
6,22.0,Nausea,6,16112042
7,22.0,Vomiting,1,16112042
8,22.0,Stomatitis,6,16112042
9,22.0,Dyspepsia,3,16112042
10,22.0,Syncope,6,16112042
11,22.0,Blood creatinine increased,2,16112042
12,22.0,Blood potassium decreased,3,16112042
13,22.0,Blood magnesium decreased,1,16112042
14,22.0,Weight decreased,6,16112042
0,22.1,Cytopenia,6,16112150
1,22.1,Fatigue,6,16112150
2,22.1,Underdose,6,16112150
3,22.1,White blood cell count decreased,2,16112150
4,22.1,Blood urea increased,6,16112150
5,22.1,Rash,1,16112150
6,22.1,Neutrophil count decreased,6,16112150
7,22.1,Eosinophil count increased,6,16112150
8,22.1,Blood pressure increased,2,16112150
9,22.1,Dyspepsia,6,16112150
10,22.1,Abdominal discomfort,2,16112150
11,22.1,Red blood cell count decreased,2,16112150
12,22.1,Haemoglobin decreased,6,16112150
13,22.1,Urinary tract infection,6,16112150
0,21.1,Fatigue,6,16112180
1,21.1,Cardiac dysfunction,6,16112180
2,21.1,Arrhythmia,6,16112180
3,21.1,Hyperglycaemia,6,16112180
4,21.1,Hepatic function abnormal,6,16112180
5,21.1,Hypertriglyceridaemia,6,16112180
0,22.0,Prostate cancer,6,16112183
1,22.0,Ureteric perforation,6,16112183
2,22.0,Abdominal pain upper,1,16112183
0,21.1,Hypokalaemia,1,16112184
1,21.1,Fanconi syndrome,1,16112184
2,21.1,Blood phosphorus decreased,1,16112184
0,22.0,Sensory loss,3,16112185
1,22.0,Prostatic specific antigen increased,3,16112185
0,21.1,Ejection fraction decreased,3,16112186
1,21.1,Cardiac failure,3,16112186
2,21.1,Acute pulmonary oedema,3,16112186
0,21.1,Lymphopenia,1,16112187
1,21.1,Thrombocytopenia,3,16112187
2,21.1,Neutropenia,3,16112187
0,21.1,Product use in unapproved indication,6,16112272
1,21.1,Therapeutic response unexpected,6,16112272
0,21.1,Hypotension,1,16112359
1,21.1,Pyrexia,1,16112359
2,21.1,Back pain,1,16112359
0,21.1,Anaphylactic reaction,1,16112370
0,22.0,Death,5,16112421
0,21.1,Renal failure,6,16112423
0,22.0,Rash pruritic,3,16112444
1,22.0,Epistaxis,3,16112444
2,22.0,Alopecia,3,16112444
3,22.0,Chills,6,16112444
4,22.0,Rhinorrhoea,6,16112444
5,22.0,Fatigue,2,16112444
6,22.0,White blood cell count decreased,6,16112444
7,22.0,Oropharyngeal pain,6,16112444
8,22.0,Headache,6,16112444
9,22.0,Nausea,2,16112444
10,22.0,Product dose omission,6,16112444
11,22.0,Nasopharyngitis,6,16112444
12,22.0,Malaise,6,16112444
13,22.0,Skin discolouration,3,16112444
0,21.1,Alopecia,3,16112483
1,21.1,Rhinorrhoea,3,16112483
2,21.1,Dry eye,6,16112483
3,21.1,Lacrimation increased,3,16112483
4,21.1,Dry skin,3,16112483
0,21.1,Abdominal pain,2,16112484
1,21.1,Diarrhoea,2,16112484
2,21.1,Faeces discoloured,2,16112484
3,21.1,Malaise,6,16112484
0,22.0,Influenza like illness,3,16112486
1,22.0,Nasopharyngitis,3,16112486
2,22.0,Insomnia,6,16112486
3,22.0,Chills,3,16112486
0,22.0,Hair colour changes,3,16112578
1,22.0,Hair disorder,3,16112578
2,22.0,Hair texture abnormal,3,16112578
3,22.0,Alopecia,3,16112578
4,22.0,Madarosis,3,16112578
0,22.0,Hair texture abnormal,3,16112584
1,22.0,Madarosis,3,16112584
2,22.0,Hair disorder,3,16112584
3,22.0,Alopecia,3,16112584
4,22.0,Hair colour changes,3,16112584
0,21.1,Fatigue,6,16112601
1,21.1,Pain in extremity,6,16112601
2,21.1,Paraesthesia,6,16112601
3,21.1,Pain,6,16112601
4,21.1,Polyneuropathy,6,16112601
5,21.1,Arthralgia,6,16112601
0,21.1,Pleural effusion,6,16112620
1,21.1,Eczema,6,16112620
2,21.1,Off label use,6,16112620
0,21.1,Hepatic failure,5,16112623
1,21.1,Drug ineffective,6,16112623
0,22.0,Alopecia,6,16112631
1,22.0,Malignant neoplasm progression,6,16112631
2,22.0,Nausea,1,16112631
3,22.0,Dysgeusia,6,16112631
4,22.0,Weight increased,6,16112631
5,22.0,General physical health deterioration,3,16112631
0,22.0,Malignant neoplasm progression,5,16112654
1,22.0,Pleural effusion,6,16112654
2,22.0,Lung infection,6,16112654
3,22.0,Malaise,3,16112654
4,22.0,Vertigo,1,16112654
5,22.0,Weight decreased,2,16112654
6,22.0,Pyrexia,1,16112654
7,22.0,Cough,3,16112654
0,22.1,Hypersomnia,6,16112674
1,22.1,Dizziness,6,16112674
2,22.1,Fatigue,3,16112674
3,22.1,Abnormal dreams,6,16112674
4,22.1,Constipation,3,16112674
5,22.1,Burning sensation,6,16112674
6,22.1,Paraesthesia,6,16112674
7,22.1,Weight decreased,6,16112674
8,22.1,Decreased appetite,6,16112674
0,22.0,Death,5,16112675
1,22.0,Product use in unapproved indication,6,16112675
0,22.0,Death,5,16112689
1,22.0,Product use in unapproved indication,6,16112689
0,22.0,Death,5,16112711
0,21.1,Dehydration,3,16112763
1,21.1,Malaise,3,16112763
2,21.1,Encephalopathy,3,16112763
0,21.1,Serum sickness-like reaction,2,16112784
1,21.1,Skin necrosis,2,16112784
2,21.1,Pruritus,2,16112784
3,21.1,Tremor,2,16112784
4,21.1,Body temperature increased,2,16112784
0,21.1,Hypertension,2,16112846
1,21.1,Transient ischaemic attack,1,16112846
0,21.1,Cardiac arrest,5,16112857
0,21.1,Respiratory arrest,5,16112861
1,21.1,Dyspnoea,6,16112861
2,21.1,Back pain,6,16112861
3,21.1,Condition aggravated,6,16112861
0,21.1,Product use in unapproved indication,6,16112896
1,21.1,Drug effective for unapproved indication,6,16112896
0,21.1,Respiratory failure,6,16112970
1,21.1,Neutrophil count decreased,6,16112970
2,21.1,Small cell lung cancer,6,16112970
3,21.1,Pneumonia,6,16112970
4,21.1,White blood cell count decreased,6,16112970
5,21.1,Malignant neoplasm progression,6,16112970
0,21.1,Bone marrow failure,6,16113040
1,21.1,Immune thrombocytopenic purpura,6,16113040
2,21.1,Pleural neoplasm,6,16113040
3,21.1,Platelet count decreased,6,16113040
0,21.1,Cardiac failure,6,16113041
1,21.1,Neurotoxicity,6,16113041
2,21.1,Left ventricular dysfunction,6,16113041
3,21.1,Infection,6,16113041
4,21.1,Febrile neutropenia,6,16113041
5,21.1,Neutropenia,6,16113041
6,21.1,Diarrhoea,6,16113041
0,22.0,Pancytopenia,1,16113155
1,22.0,Acute kidney injury,1,16113155
0,21.1,Rash pruritic,1,16113170
1,21.1,Throat irritation,1,16113170
2,21.1,Pruritus,1,16113170
3,21.1,Infusion related reaction,1,16113170
0,21.1,Tumour necrosis,5,16113172
1,21.1,Pleural disorder,5,16113172
0,22.0,Ejection fraction decreased,1,16113173
1,22.0,Colitis,1,16113173
2,22.0,General physical health deterioration,1,16113173
3,22.0,Diarrhoea,2,16113173
4,22.0,Large intestine infection,1,16113173
0,21.1,Influenza A virus test positive,3,16113176
1,21.1,Respiratory failure,5,16113176
2,21.1,Bacteraemia,3,16113176
3,21.1,Pneumonia,3,16113176
4,21.1,Neutropenia,3,16113176
0,21.1,Ischaemic stroke,2,16113177
0,21.1,Death,5,16113179
0,21.1,Alopecia,1,16113217
1,21.1,Decreased appetite,1,16113217
2,21.1,Asthenia,1,16113217
3,21.1,Ligamentitis,1,16113217
4,21.1,Musculoskeletal stiffness,1,16113217
5,21.1,Dry skin,1,16113217
6,21.1,Neuropathy peripheral,1,16113217
7,21.1,Joint stiffness,1,16113217
0,21.1,Death,5,16113220
0,21.1,Dermatitis bullous,1,16113232
0,21.1,Hepatocellular injury,5,16113236
0,22.0,Neoplasm progression,5,16113241
1,22.0,Neutrophil count decreased,1,16113241
0,21.1,Death,5,16113243
0,21.1,Hepatic cirrhosis,6,16113245
1,21.1,Death,5,16113245
0,21.1,Nephrostomy,6,16113252
1,21.1,Anaemia,6,16113252
2,21.1,Prescription drug used without a prescription,6,16113252
3,21.1,Off label use,6,16113252
4,21.1,Cardiac failure,6,16113252
0,22.0,Constipation,1,16113300
1,22.0,Catheter site infection,1,16113300
2,22.0,Oedema peripheral,1,16113300
3,22.0,Ascites,1,16113300
0,21.1,Product use in unapproved indication,6,16113321
1,21.1,Dyspnoea,2,16113321
2,21.1,Pneumonitis,6,16113321
0,22.0,Stomatitis,3,16113324
1,22.0,Constipation,3,16113324
2,22.0,Malaise,1,16113324
0,22.0,Alopecia,6,16113352
1,22.0,Platelet count decreased,6,16113352
2,22.0,Limb injury,6,16113352
3,22.0,White blood cell count decreased,6,16113352
4,22.0,Hot flush,6,16113352
5,22.0,Mouth injury,6,16113352
0,22.0,Fatigue,6,16113369
1,22.0,Full blood count decreased,6,16113369
2,22.0,Nausea,6,16113369
3,22.0,White blood cell count decreased,1,16113369
4,22.0,Neutrophil count decreased,6,16113369
0,22.1,White blood cell count decreased,6,16113375
0,22.0,Amnesia,6,16113403
1,22.0,Feeling abnormal,6,16113403
2,22.0,Post procedural persistent drain fluid,6,16113403
3,22.0,Neuralgia,6,16113403
4,22.0,Pain,6,16113403
5,22.0,White blood cell count decreased,6,16113403
6,22.0,Nasopharyngitis,6,16113403
0,22.0,Delusional perception,6,16113470
1,22.0,Confusional state,6,16113470
2,22.0,Insomnia,6,16113470
3,22.0,Decreased appetite,6,16113470
4,22.0,Chromaturia,6,16113470
5,22.0,Proctalgia,6,16113470
6,22.0,Knee deformity,6,16113470
7,22.0,Blood urine present,6,16113470
8,22.0,Pneumonia,6,16113470
9,22.0,Cystitis,6,16113470
10,22.0,Vomiting,6,16113470
11,22.0,Urinary incontinence,6,16113470
12,22.0,Urinary tract infection,6,16113470
13,22.0,Pain,6,16113470
14,22.0,Fall,6,16113470
15,22.0,Asthenia,6,16113470
16,22.0,Disorientation,6,16113470
17,22.0,Loss of consciousness,6,16113470
18,22.0,Malaise,6,16113470
19,22.0,Dehydration,6,16113470
20,22.0,Back pain,6,16113470
21,22.0,Dizziness,6,16113470
22,22.0,Urine odour abnormal,6,16113470
23,22.0,Product dose omission,6,16113470
24,22.0,Neoplasm progression,6,16113470
25,22.0,Respiratory tract congestion,6,16113470
26,22.0,Depression,6,16113470
27,22.0,Musculoskeletal stiffness,6,16113470
0,21.1,Neoplasm progression,6,16113473
0,21.1,Alopecia,3,16113480
1,21.1,Hair disorder,3,16113480
2,21.1,Hair colour changes,3,16113480
3,21.1,Hair texture abnormal,3,16113480
4,21.1,Madarosis,6,16113480
0,21.1,No adverse event,6,16113700
1,21.1,Product dose omission,6,16113700
0,22.0,Cytopenia,1,16113720
1,22.0,Platelet count decreased,6,16113720
2,22.0,Pathological fracture,6,16113720
3,22.0,Pain,6,16113720
4,22.0,Neutropenia,1,16113720
5,22.0,Vomiting,3,16113720
6,22.0,Nausea,3,16113720
7,22.0,White blood cell count decreased,6,16113720
8,22.0,Neoplasm progression,6,16113720
0,21.1,Renal failure,6,16113721
1,21.1,Vomiting,6,16113721
0,21.1,Leukoencephalopathy,2,16113723
0,21.1,Acute kidney injury,3,16113724
1,21.1,Pancytopenia,3,16113724
0,21.1,Anaemia,1,16113734
0,21.1,Death,5,16113827
0,21.1,Death,5,16113848
0,21.1,Death,5,16113849
0,21.1,Death,5,16113850
0,21.1,Product dose omission,6,16113885
1,21.1,No adverse event,6,16113885
0,21.1,Disseminated intravascular coagulation,2,16113973
0,21.1,Neoplasm progression,6,16114435
1,21.1,Death,5,16114435
0,21.1,White blood cell count decreased,1,16114437
1,21.1,Agranulocytosis,1,16114437
0,21.1,Superior vena cava syndrome,6,16114538
0,21.1,Myeloid leukaemia,3,16114564
0,22.0,Pain,3,16114583
1,22.0,Malaise,1,16114583
2,22.0,Fatigue,6,16114583
3,22.0,Quality of life decreased,6,16114583
4,22.0,Tremor,1,16114583
5,22.0,Insomnia,3,16114583
6,22.0,Palpitations,6,16114583
7,22.0,Bone pain,1,16114583
8,22.0,Blood pressure systolic increased,6,16114583
9,22.0,Emotional distress,1,16114583
10,22.0,Amnesia,1,16114583
11,22.0,Muscle atrophy,6,16114583
12,22.0,Cataract,6,16114583
13,22.0,Ligament pain,1,16114583
14,22.0,Adverse event,1,16114583
15,22.0,Cognitive disorder,6,16114583
16,22.0,Hypersensitivity,6,16114583
0,21.1,Interstitial lung disease,6,16114617
0,21.1,Second primary malignancy,3,16114645
1,21.1,Acute myeloid leukaemia,3,16114645
0,21.1,Hepatitis acute,2,16114648
0,22.0,Malaise,1,16114674
1,22.0,Loss of consciousness,1,16114674
2,22.0,Hyperthermia,1,16114674
3,22.0,Tachycardia,1,16114674
0,21.1,Vomiting,1,16114684
1,21.1,Erythema,1,16114684
0,21.1,Axillary pain,6,16114706
1,21.1,Pericardial effusion,6,16114706
0,21.1,Gastric cancer,5,16114708
1,21.1,Constipation,3,16114708
0,22.0,Urinary tract obstruction,6,16114776
1,22.0,Device related infection,6,16114776
2,22.0,Urinary retention,6,16114776
3,22.0,Acidosis,6,16114776
4,22.0,Hospitalisation,2,16114776
5,22.0,Acute kidney injury,6,16114776
6,22.0,Pyelonephritis acute,2,16114776
0,21.1,Venous thrombosis,1,16114788
0,21.1,Impaired healing,2,16114821
1,21.1,Off label use,6,16114821
0,21.1,Abdominal discomfort,1,16114824
1,21.1,Thrombocytopenia,1,16114824
2,21.1,Anaemia,1,16114824
3,21.1,Decreased appetite,6,16114824
4,21.1,Anxiety,1,16114824
5,21.1,Gastric disorder,6,16114824
6,21.1,Nausea,2,16114824
7,21.1,White blood cell count decreased,3,16114824
8,21.1,Biliary colic,3,16114824
9,21.1,Dehydration,3,16114824
10,21.1,Hypophagia,1,16114824
11,21.1,Asthenia,3,16114824
12,21.1,Oral pain,3,16114824
13,21.1,Constipation,1,16114824
14,21.1,Product dose omission,6,16114824
15,21.1,Gastritis,1,16114824
16,21.1,Weight decreased,6,16114824
0,21.1,Malignant neoplasm progression,5,16114826
1,21.1,Nausea,6,16114826
2,21.1,Gastritis,3,16114826
3,21.1,Bone marrow failure,1,16114826
4,21.1,Vomiting,6,16114826
0,21.1,Respiratory distress,6,16114885
1,21.1,Alopecia,6,16114885
2,21.1,Rhinitis,6,16114885
3,21.1,Pain in extremity,6,16114885
4,21.1,Onycholysis,6,16114885
5,21.1,Gastritis,6,16114885
0,21.1,Injection site haematoma,6,16114910
1,21.1,Sciatica,6,16114910
2,21.1,Injection site pain,6,16114910
3,21.1,Induration,6,16114910
0,21.1,Hypokalaemia,1,16114915
1,21.1,Hyponatraemia,1,16114915
0,21.1,Pulmonary embolism,6,16114917
1,21.1,Internal haemorrhage,6,16114917
0,21.1,Hospitalisation,6,16114918
0,22.0,Ejection fraction decreased,1,16114956
1,22.0,Large intestine infection,1,16114956
2,22.0,General physical health deterioration,1,16114956
3,22.0,Colitis,1,16114956
4,22.0,Ejection fraction decreased,1,16114956
5,22.0,Diarrhoea,2,16114956
0,22.0,Pubis fracture,1,16114959
1,22.0,Fall,1,16114959
2,22.0,Leucine aminopeptidase increased,3,16114959
3,22.0,Blood test abnormal,2,16114959
0,22.0,Uveitis,2,16114970
1,22.0,Glaucoma,2,16114970
0,22.0,Dysphagia,6,16114980
1,22.0,Retching,6,16114980
2,22.0,Cardiac arrest,5,16114980
3,22.0,Choking,6,16114980
0,21.1,Tachycardia,2,16114991
1,21.1,Rash,2,16114991
2,21.1,Flushing,2,16114991
3,21.1,Abdominal pain,2,16114991
0,22.0,Interstitial lung disease,3,16115000
1,22.0,Raynaud^s phenomenon,3,16115000
0,21.1,Death,5,16115095
0,22.0,Gait disturbance,6,16115165
1,22.0,Urinary retention,6,16115165
2,22.0,Peripheral sensory neuropathy,2,16115165
3,22.0,Spinal cord compression,6,16115165
4,22.0,Peripheral motor neuropathy,3,16115165
0,21.1,Infusion site infection,6,16115197
0,21.1,Infusion site infection,6,16115209
0,21.1,Dermatitis acneiform,1,16115220
0,22.0,Metastases to central nervous system,5,16115225
1,22.0,Malignant neoplasm progression,5,16115225
2,22.0,Decreased appetite,6,16115225
3,22.0,Nausea,3,16115225
4,22.0,Wrong technique in product usage process,6,16115225
5,22.0,Depressed level of consciousness,6,16115225
6,22.0,Dysphagia,6,16115225
7,22.0,Non-small cell lung cancer stage IV,5,16115225
0,21.1,Effusion,6,16115226
0,22.1,Arthralgia,1,16115293
1,22.1,Myalgia,1,16115293
2,22.1,Hypothalamo-pituitary disorder,1,16115293
0,22.1,Fatigue,3,16115325
1,22.1,Alopecia,3,16115325
2,22.1,Bradyphrenia,6,16115325
3,22.1,Joint range of motion decreased,6,16115325
4,22.1,Diverticulitis,3,16115325
5,22.1,Diarrhoea,6,16115325
6,22.1,Muscular weakness,6,16115325
7,22.1,Hair disorder,3,16115325
8,22.1,Madarosis,3,16115325
9,22.1,Gait disturbance,6,16115325
0,21.1,Asthenia,6,16115331
1,21.1,Nausea,1,16115331
2,21.1,Pain,6,16115331
3,21.1,White blood cell count decreased,6,16115331
4,21.1,Platelet count decreased,6,16115331
0,21.1,Death,5,16115357
0,21.1,Death,5,16115358
0,21.1,Malignant neoplasm progression,5,16115359
0,21.1,Death,5,16115365
0,22.0,Cerebral disorder,5,16115375
1,22.0,Infection,3,16115375
2,22.0,Monoparesis,4,16115375
0,21.1,Drug interaction,2,16115408
1,21.1,Haemorrhagic transformation stroke,2,16115408
0,21.1,Chills,1,16115418
0,22.0,Immune-mediated pneumonitis,2,16115419
0,21.1,Bone marrow toxicity,6,16115432
1,21.1,Neutropenia,6,16115432
2,21.1,Thrombocytopenia,6,16115432
0,21.1,Pyrexia,6,16115435
1,21.1,Splenic infarction,6,16115435
2,21.1,Febrile neutropenia,1,16115435
3,21.1,Product use in unapproved indication,6,16115435
0,22.0,Inappropriate schedule of product administration,6,16115436
1,22.0,Ataxia,5,16115436
2,22.0,Brain oedema,5,16115436
3,22.0,Malignant neoplasm progression,5,16115436
4,22.0,Metastases to central nervous system,5,16115436
0,21.1,Renal failure,2,16115444
1,21.1,Hyperglycaemia,1,16115444
2,21.1,Steroid diabetes,1,16115444
0,21.1,Malaise,1,16115499
1,21.1,Body temperature decreased,1,16115499
2,21.1,Blood magnesium decreased,1,16115499
0,21.1,Wheezing,1,16115500
1,21.1,Malaise,1,16115500
2,21.1,Fatigue,1,16115500
3,21.1,Dyspnoea,1,16115500
0,22.0,Death,5,16115561
1,22.0,Product use in unapproved indication,6,16115561
0,21.1,Pruritus,3,16115611
1,21.1,Eczema,3,16115611
0,22.0,Hyperglycaemia,2,16115640
1,22.0,Urinary tract infection,1,16115640
2,22.0,Lung infection,1,16115640
3,22.0,Pneumothorax,1,16115640
0,21.1,Photopsia,1,16115649
0,22.0,Adverse event,6,16115701
1,22.0,Adverse event,6,16115701
2,22.0,Product use in unapproved indication,6,16115701
3,22.0,Adverse event,6,16115701
4,22.0,Adverse event,6,16115701
0,21.1,Anaemia,6,16115713
0,21.1,Pyrexia,6,16115744
1,21.1,Mucosal inflammation,6,16115744
0,21.1,Febrile neutropenia,1,16115772
1,21.1,Splenic infarction,1,16115772
2,21.1,Hepatosplenomegaly,1,16115772
0,22.0,Adverse event,6,16115803
1,22.0,Adverse event,6,16115803
2,22.0,Inappropriate schedule of product administration,6,16115803
3,22.0,Adverse event,6,16115803
0,22.0,Toe amputation,,16115900
1,22.0,Erythema,,16115900
2,22.0,Foot deformity,,16115900
3,22.0,Pain,,16115900
4,22.0,Peripheral swelling,,16115900
5,22.0,Osteomyelitis,,16115900
0,21.1,Hyperhidrosis,2,16115914
1,21.1,Hypotension,2,16115914
2,21.1,Abdominal pain upper,2,16115914
3,21.1,Off label use,2,16115914
0,21.1,Gallbladder polyp,6,16115916
1,21.1,Mouth ulceration,6,16115916
2,21.1,Cholecystitis chronic,6,16115916
3,21.1,Breath odour,6,16115916
0,21.1,Left ventricular dysfunction,1,16115920
0,22.1,Renal cancer metastatic,5,16115938
1,22.1,Accidental overdose,6,16115938
2,22.1,Decreased appetite,6,16115938
3,22.1,Shock,1,16115938
4,22.1,Dehydration,1,16115938
5,22.1,Shock haemorrhagic,1,16115938
6,22.1,Staphylococcal infection,1,16115938
7,22.1,Cell death,1,16115938
8,22.1,Coma,1,16115938
9,22.1,Metastases to central nervous system,5,16115938
10,22.1,Diarrhoea,1,16115938
11,22.1,General physical health deterioration,6,16115938
12,22.1,Hypothyroidism,2,16115938
13,22.1,Oedema peripheral,6,16115938
14,22.1,Urinary incontinence,3,16115938
15,22.1,Psychomotor retardation,1,16115938
16,22.1,Asthenia,1,16115938
17,22.1,Malignant neoplasm progression,5,16115938
18,22.1,Peripheral artery haematoma,6,16115938
19,22.1,Metabolic acidosis,6,16115938
20,22.1,Heart rate decreased,6,16115938
21,22.1,Vomiting,1,16115938
22,22.1,Pneumonia,2,16115938
23,22.1,Blood pressure systolic decreased,6,16115938
24,22.1,Malnutrition,1,16115938
25,22.1,Pruritus,1,16115938
26,22.1,Acute kidney injury,2,16115938
27,22.1,Blood pressure systolic increased,6,16115938
28,22.1,Hyperkalaemia,1,16115938
29,22.1,Anaemia,1,16115938
30,22.1,Vitamin D deficiency,1,16115938
31,22.1,Constipation,1,16115938
32,22.1,Lactic acidosis,2,16115938
33,22.1,Staphylococcal sepsis,2,16115938
34,22.1,Hyperleukocytosis,1,16115938
35,22.1,Haematoma,6,16115938
36,22.1,Intestinal transit time abnormal,1,16115938
0,22.0,Eosinophilic pneumonia,2,16115944
0,21.1,Aspartate aminotransferase increased,3,16115963
1,21.1,Alanine aminotransferase increased,3,16115963
2,21.1,Amylase increased,3,16115963
3,21.1,Blood bilirubin increased,3,16115963
4,21.1,Lipase increased,3,16115963
0,21.1,Malignant neoplasm progression,6,16115967
1,21.1,Acne,1,16115967
0,22.0,Urticaria,,16115993
1,22.0,Contrast media reaction,,16115993
0,21.1,Pancytopenia,5,16116000
1,21.1,Diarrhoea,5,16116000
2,21.1,Mucosal inflammation,5,16116000
0,22.0,Throat tightness,,16116002
1,22.0,Back pain,,16116002
2,22.0,Chest discomfort,,16116002
3,22.0,Flushing,,16116002
0,21.1,Hepatic failure,5,16116013
0,22.0,Death,,16116016
0,22.0,Staphylococcal infection,3,16116025
1,22.0,Confusional state,6,16116025
2,22.0,Pain,6,16116025
3,22.0,Aneurysm,6,16116025
4,22.0,Fall,6,16116025
5,22.0,Cellulitis,3,16116025
6,22.0,Dysphagia,6,16116025
7,22.0,Fibromyalgia,6,16116025
8,22.0,Sleep apnoea syndrome,6,16116025
9,22.0,Encephalitis,6,16116025
10,22.0,Malaise,6,16116025
11,22.0,Malignant neoplasm progression,6,16116025
12,22.0,Drug intolerance,6,16116025
13,22.0,Pyrexia,6,16116025
14,22.0,Immobile,6,16116025
15,22.0,Seizure,6,16116025
16,22.0,Dyspnoea,6,16116025
0,21.1,Pain in extremity,2,16116075
1,21.1,Device related infection,6,16116075
0,22.0,Unintentional medical device removal,6,16116091
0,21.1,Constipation,1,16116096
1,21.1,Diarrhoea,1,16116096
2,21.1,Dyspnoea,1,16116096
3,21.1,Diarrhoea,1,16116096
4,21.1,Dizziness,1,16116096
5,21.1,Retinal detachment,4,16116096
6,21.1,Weight decreased,1,16116096
7,21.1,Nausea,1,16116096
8,21.1,Back pain,1,16116096
9,21.1,Ejection fraction decreased,1,16116096
10,21.1,Fatigue,3,16116096
11,21.1,Pleural effusion,1,16116096
12,21.1,Alopecia,1,16116096
13,21.1,Presyncope,1,16116096
0,22.0,Pain,6,16116121
1,22.0,Alopecia,3,16116121
2,22.0,Emotional distress,6,16116121
3,22.0,Anxiety,6,16116121
4,22.0,Impaired quality of life,6,16116121
5,22.0,Psychological trauma,6,16116121
0,21.1,Impaired quality of life,6,16116126
1,21.1,Anxiety,6,16116126
2,21.1,Alopecia,3,16116126
3,21.1,Pain,6,16116126
4,21.1,Emotional distress,6,16116126
0,22.0,Psychological trauma,6,16116176
1,22.0,Alopecia,3,16116176
2,22.0,Anxiety,6,16116176
3,22.0,Pain,6,16116176
4,22.0,Emotional distress,6,16116176
5,22.0,Impaired quality of life,6,16116176
0,22.1,Constipation,3,16116183
1,22.1,Acute kidney injury,1,16116183
2,22.1,Dehydration,1,16116183
3,22.1,Diarrhoea,1,16116183
4,22.1,Decreased appetite,6,16116183
5,22.1,Malaise,1,16116183
6,22.1,Asthenia,6,16116183
7,22.1,Nausea,1,16116183
8,22.1,Vomiting,1,16116183
0,21.1,Protein total decreased,6,16116189
0,22.0,Wrong technique in product usage process,6,16116232
0,21.1,Respiratory tract infection,1,16116241
0,21.1,Bone marrow failure,6,16116250
1,21.1,Pneumonitis,6,16116250
2,21.1,Hepatic steatosis,6,16116250
3,21.1,Renal cyst,6,16116250
4,21.1,Tonsillitis,6,16116250
5,21.1,Sinusitis,6,16116250
6,21.1,Drug resistance,6,16116250
0,21.1,Bone marrow failure,6,16116274
0,21.1,Back pain,2,16116301
1,21.1,Diarrhoea,2,16116301
0,21.1,Prostate cancer,5,16116339
0,22.0,Hyponatraemia,1,16116359
0,21.1,Death,5,16116372
0,22.0,Loss of consciousness,5,16116380
0,22.0,Hypertension,1,16116382
1,22.0,Pulmonary embolism,3,16116382
0,22.0,Product use in unapproved indication,6,16116389
1,22.0,Death,5,16116389
0,21.1,Diarrhoea,3,16116401
1,21.1,Nail bed inflammation,3,16116401
2,21.1,Dermatitis,3,16116401
3,21.1,Rhinitis,3,16116401
4,21.1,Skin fissures,3,16116401
5,21.1,Constipation,3,16116401
6,21.1,Peripheral sensory neuropathy,1,16116401
7,21.1,Dermatitis bullous,3,16116401
8,21.1,Anaemia,1,16116401
0,21.1,Prostatic specific antigen increased,6,16116427
1,21.1,Epidural lipomatosis,6,16116427
2,21.1,Malignant neoplasm progression,6,16116427
3,21.1,Lumbar spinal stenosis,6,16116427
0,22.0,Transient ischaemic attack,1,16116442
1,22.0,Hypertension,2,16116442
0,22.0,Cataract,6,16116457
1,22.0,Embolism,5,16116457
0,21.1,Influenza,1,16116477
1,21.1,Starvation,1,16116477
2,21.1,Mucosal inflammation,1,16116477
0,21.1,Pneumonia,5,16116483
0,21.1,Interstitial lung disease,6,16116539
1,21.1,Interstitial lung disease,2,16116539
2,21.1,Lymphangiosis carcinomatosa,6,16116539
0,22.1,General physical health deterioration,3,16116540
0,21.1,Bone marrow failure,2,16116556
0,21.1,Pulmonary embolism,2,16116578
1,21.1,Off label use,6,16116578
2,21.1,Deep vein thrombosis,2,16116578
0,22.0,Drug interaction,6,16116581
1,22.0,Epistaxis,1,16116581
2,22.0,Rectal haemorrhage,1,16116581
0,21.1,Musculoskeletal pain,2,16116584
1,21.1,Colitis,1,16116584
0,21.1,Bone marrow failure,2,16116611
1,21.1,Mucosal inflammation,2,16116611
2,21.1,Pyrexia,2,16116611
0,22.0,Pneumonia,2,16116613
1,22.0,Nausea,2,16116613
2,22.0,Diarrhoea,2,16116613
0,21.1,Dyspnoea,1,16116616
1,21.1,Hypersensitivity,6,16116616
2,21.1,Pallor,1,16116616
3,21.1,Bronchospasm,1,16116616
4,21.1,Hypotension,1,16116616
0,22.0,Gastrooesophageal reflux disease,2,16116619
1,22.0,Musculoskeletal pain,2,16116619
2,22.0,Cough,2,16116619
3,22.0,Rectal haemorrhage,2,16116619
4,22.0,Abdominal pain upper,2,16116619
5,22.0,Abdominal pain,2,16116619
6,22.0,Nausea,2,16116619
7,22.0,Decreased appetite,2,16116619
8,22.0,Anaemia,2,16116619
9,22.0,Pyrexia,2,16116619
0,21.1,Lung infiltration,1,16116627
0,21.1,Infusion related reaction,1,16116692
1,21.1,Hypertension,1,16116692
2,21.1,Chills,1,16116692
0,22.1,Syncope,6,16116717
1,22.1,Seizure,6,16116717
2,22.1,Muscle rigidity,6,16116717
3,22.1,Death,5,16116717
4,22.1,Intentional product use issue,6,16116717
5,22.1,Off label use,6,16116717
0,21.1,Stomatitis,6,16116718
1,21.1,Sepsis,6,16116718
2,21.1,Vena cava thrombosis,6,16116718
3,21.1,Neuropathy peripheral,6,16116718
4,21.1,Hypotension,6,16116718
5,21.1,Drug hypersensitivity,6,16116718
6,21.1,Oral candidiasis,6,16116718
7,21.1,Vomiting,6,16116718
8,21.1,Asthenia,6,16116718
9,21.1,Hypertension,6,16116718
10,21.1,Paraesthesia,6,16116718
11,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,16116718
12,21.1,Neutropenia,6,16116718
13,21.1,Leukopenia,6,16116718
14,21.1,Subdural haematoma,6,16116718
15,21.1,Tumour haemorrhage,6,16116718
16,21.1,Diarrhoea,6,16116718
17,21.1,Abdominal pain,6,16116718
18,21.1,Nausea,6,16116718
19,21.1,Thrombocytopenia,6,16116718
20,21.1,Dystonia,6,16116718
21,21.1,Anaemia,6,16116718
22,21.1,Fatigue,6,16116718
23,21.1,Urinary tract infection,6,16116718
0,22.0,Metastatic neoplasm,5,16116725
1,22.0,Feeding disorder,5,16116725
2,22.0,Asthenia,5,16116725
0,21.1,Diabetes mellitus,2,16116811
1,21.1,Interstitial lung disease,2,16116811
0,21.1,Brain oedema,1,16116818
0,21.1,Ischaemic stroke,4,16116828
0,21.1,Colitis ischaemic,2,16116857
0,22.0,Myelodysplastic syndrome,2,16116858
0,21.1,Anaphylactic shock,6,16116903
